9th Circ. Revives Shareholder Suit Over Arena's Diet Drug
The Ninth Circuit on Wednesday revived a proposed class action against Arena Pharmaceuticals alleging the company lied to shareholders about tests for a diet drug, finding that even though the drug...To view the full article, register now.
Already a subscriber? Click here to view full article